Christina Louise Derleth

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan, Shannon J. Turley, Dorothee Nickles et al. · Nature · 2018 · 5.2K citations · Full text

Tumor Biology, Cancer Immunosurveillance, Tumour Response +12

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Thomas Powles, Ignacio Durán, Michiel S. van der Heijden et al. · The Lancet · 2017 · 1.4K citations · Full text

Urology, Metastatic Urothelial Carcinoma, Genitourinary Cancer +6

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study

Andrea Necchi, Richard W. Joseph, Yohann Loriot et al. · Annals of Oncology · 2017 · 315 citations · Full text

Urology, Metastatic Urothelial Carcinoma, Post-progression Outcomes +7

The Influence of Age, Gender, and Training on Exercise Efficiency

Janghee Woo, Christina Louise Derleth, John R. Stratton et al. · Journal of the American College of Cardiology · 2006 · 176 citations

Exercise Efficiency, Physical Activity, Kinesiology +10

Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States

Matthew D. Galsky, Sumanta K. Pal, Shih‐Wen Lin et al. · Bladder Cancer · 2018 · 78 citations · Full text